151 related articles for article (PubMed ID: 27216771)
1. Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test.
Plumb AA; Ghanouni A; Rainbow S; Djedovic N; Marshall S; Stein J; Taylor SA; Halligan S; Lyratzopoulos G; von Wagner C
J Med Screen; 2017 Mar; 24(1):12-19. PubMed ID: 27216771
[TBL] [Abstract][Full Text] [Related]
2. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
3. High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.
Brown JP; Wooldrage K; Wright S; Nickerson C; Cross AJ; Atkin WS
J Med Screen; 2018 Jun; 25(2):70-75. PubMed ID: 28467146
[TBL] [Abstract][Full Text] [Related]
4. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
5. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
7. Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: data from the English Bowel Cancer Screening Programme.
Bevan R; Lee TJ; Nickerson C; Rubin G; Rees CJ;
J Med Screen; 2014 Jun; 21(2):89-94. PubMed ID: 24644029
[TBL] [Abstract][Full Text] [Related]
8. Repeated faecal occult blood testing is associated with decreased advanced colorectal cancer risk: A population-based study.
James PD; Rabeneck L; Yun L; Paszat L; Baxter NN; Govindarajan A; Antonova L; Tinmouth JM
J Med Screen; 2018 Sep; 25(3):141-148. PubMed ID: 28862521
[TBL] [Abstract][Full Text] [Related]
9. Harms of colonoscopy in a colorectal cancer screening programme with faecal occult blood test: a population-based cohort study.
Denis B; Gendre I; Sauleau EA; Lacroute J; Perrin P
Dig Liver Dis; 2013 Jun; 45(6):474-80. PubMed ID: 23414583
[TBL] [Abstract][Full Text] [Related]
10. The Direct Access Colonoscopy Clinic: Improving time to colonoscopy for eligible positive faecal occult blood test patients in Broken Hill NSW.
Whitelaw L; Hammond K; Cumming M; Mansfield K; Saurman E
Aust J Rural Health; 2020 Feb; 28(1):81-86. PubMed ID: 31650635
[TBL] [Abstract][Full Text] [Related]
11. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
[TBL] [Abstract][Full Text] [Related]
12. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
13. Faecal occult blood test and colonoscopy use in Portugal: Results from the National Health Survey 2014.
Khan H; Shaaban N; Peleteiro B
J Med Screen; 2020 Dec; 27(4):171-185. PubMed ID: 31865864
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
15. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
16. Socio-geographical determinants of colonoscopy uptake after faecal occult blood test.
Dupont-Lucas C; Dejardin O; Dancourt V; Launay L; Launoy G; Guittet L
Dig Liver Dis; 2011 Sep; 43(9):714-20. PubMed ID: 21530429
[TBL] [Abstract][Full Text] [Related]
17. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.
Wong BC; Wong WM; Cheung KL; Tong TS; Rozen P; Young GP; Chu KW; Ho J; Law WL; Tung HM; Lai KC; Hu WH; Chan CK; Lam SK
Aliment Pharmacol Ther; 2003 Nov; 18(9):941-6. PubMed ID: 14616158
[TBL] [Abstract][Full Text] [Related]
18. Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population.
Fu WP; Kam MH; Ling WM; Ong SF; Suzannah N; Eu KW
Tech Coloproctol; 2009 Sep; 13(3):225-30. PubMed ID: 19629380
[TBL] [Abstract][Full Text] [Related]
19. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
20. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
